Clinical Trial Update: Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of photodynamic therapy with temoporfin for non-resectable non-small-cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Temoporfin (temoporfin)

Snippet

Sponsor: University of Arkansas | Conditions: Carcinoma, Non-Small-Cell-Lung | Phase 1 | Status: WITHDRAWN